A single arm, prospective multicenter phase II study FOLFIRINOX in patients with advanced and recurrent biliary tract cancer.

被引：3
|
作者：
Takahara, Naminatsu
Isayama, Hiroyuki
Nakai, Yousuke
Ioka, Tatsuya
Kanai, Masashi
Sasaki, Takashi
Furuse, Junji
Koike, Kazuhiko
机构：
[1] Univ Tokyo, Tokyo, Japan
[2] Univ Tokyo, Grad Sch Med, Dept Gastroenterol, Tokyo, Japan
[3] Osaka Med Ctr Canc & Cardiovasc Dis, Hepatobiliary & Pancreat Oncol, Osaka, Japan
[4] Kyoto Univ Hosp, Kyoto, Japan
[5] JFCR, Canc Inst Hosp, Tokyo, Japan
[6] Kyorin Univ, Sch Med, Dept Med Oncol, Tokyo, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷 / 04期
关键词：
D O I：
10.1200/JCO.2017.35.4_suppl.TPS514
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TPS514
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Phase II study of gemcitabine and cisplatin in advanced biliary tract cancer
    Park, Byung Kyu
    Kim, Yoon Jae
    Park, Jeong Youp
    Bang, Seungmin
    Park, Seung Woo
    Chung, Jae Bock
    Kim, Kyung Sik
    Choi, Jin-Sub
    Lee, Woo Jung
    Song, Si Young
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2006, 21 (06) : 999 - 1003
  • [32] A Phase II study of gemcitabine and cisplatin in advanced biliary tract cancer
    Kim, ST
    Park, JO
    Lee, J
    Lee, KT
    Lee, JK
    Choi, SH
    Heo, JS
    Park, YS
    Kang, WK
    Park, K
    CANCER, 2006, 106 (06) : 1339 - 1346
  • [33] Phase II study of combination paclitaxel and carboplatin in patients with advanced or recurrent endometrial cancer.
    Shan, B.
    Wang, H.
    Ren, Y.
    Tu, X.
    Jiang, Z.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [34] A multicenter, single-armed, prospective phase II study of apatinib combined with chemotherapy neoadjuvant for locally advanced gastric cancer.
    Lin, JianXian
    Huang, Changming
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [35] Gemcitabine, oxaliplatin and nab-paclitaxel as first-line treatment for patients with advanced biliary tract cancer: A multicenter, single-arm, phase I/II trial
    Pressiani, T.
    Balsano, R.
    Giordano, L.
    Milella, M.
    Bergamo, F.
    Bozzarelli, S.
    Noventa, S.
    Ferrari, D.
    Scartozzi, M.
    Parra, H. J. Soto
    Auriemma, A.
    Solda, C.
    Zaniboni, A.
    Zecchetto, C.
    Rizzato, M. D.
    Rimassa, L.
    Santoro, A.
    ANNALS OF ONCOLOGY, 2024, 35 : S120 - S120
  • [36] A multicenter phase II study of gemcitabine plus S-1 chemotherapy for advanced biliary tract cancer
    Arima, S.
    Shimizu, K.
    Okamoto, T.
    Toki, S.
    Kasuga, A.
    Kitamura, H.
    Takasu, A.
    Nagashima, F.
    Sugiyama, M.
    Furuse, J.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S627 - S627
  • [37] A Multicenter Phase II Study of Gemcitabine plus S-1 Chemotherapy for Advanced Biliary Tract Cancer
    Arima, Shiho
    Shimizu, Kyoko
    Okamoto, Tomoyoshi
    Toki, Masao
    Suzuki, Yutaka
    Okano, Naohiro
    Naruge, Daisuke
    Kawai, Kirio
    Kobayashi, Takaaki
    Kasuga, Akiyoshi
    Kitamura, Hiroshi
    Takasu, Atuko
    Nagashima, Fumio
    Sugiyama, Masanori
    Furuse, Junji
    ANTICANCER RESEARCH, 2017, 37 (02) : 909 - 914
  • [38] A phase II study to evaluate the safety and efficacy of anlotinib combined with penpulimab for advanced refractory biliary tract cancer.
    He, Xiaojun
    Tan, Kai
    Du, Xilin
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : TPS582 - TPS582
  • [39] A multicenter, single-arm, phase II study of nivolumab in patients with biliary tract cancer with a PD-L1 combined positive score ≥ 1.
    Furukawa, Masayuki
    Ueno, Makoto
    Sakai, Daisuke
    Ouchi, Kota
    Hamamoto, Yasuo
    Aikata, Hiroshi
    Ozaka, Masato
    Tsumura, Hidetaka
    Tsuji, Kunihiro
    Kubo, Shoji
    Nishina, Tomohiro
    Katanuma, Akio
    Morizane, Chigusa
    Ikeda, Masafumi
    Mizuno, Nobumasa
    Inagaki, Takashi
    Shioji, Kazuhiko
    Furuse, Junji
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 533 - 533
  • [40] Final analysis of a phase II study of modified FOLFIRINOX in locally advanced and metastatic pancreatic cancer.
    Stein, Stacey
    James, Edward Samuel
    Cong, Xiangyu
    Deng, Yanhong
    Salem, Ronald R.
    Cha, Charles
    Chang, Bryan William
    Hochster, Howard S.
    Doddamane, Indukala
    Boustani, Annmarie
    Patel, Vatsal
    Kortmansky, Jeremy S.
    Li, Jia
    Staugaard, Carol
    Lacy, Jill
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (04)
12345